FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.9.0  |  FHIR Version n/a  User: [n/a]

21495011000001103: Plenadren 20mg modified-release tablets (Takeda UK Ltd) 50 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 14-Nov 2012. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1803061000001114 Plenadren 20mg modified-release tablets (Takeda UK Ltd) 50 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1803071000001116 Plenadren 20mg modified-release tablets (Takeda UK Ltd) 50 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
71173501000001111 Plenadren 20mg modified-release tablets (ViroPharma Ltd) 50 tablet (product) en Fully specified name Inactive Entire term case sensitive SNOMED CT United Kingdom drug extension module
71173601000001110 Plenadren 20mg modified-release tablets (ViroPharma Ltd) 50 tablet en Synonym Inactive Entire term case sensitive SNOMED CT United Kingdom drug extension module
99548101000001113 Plenadren 20mg modified-release tablets (Shire Pharmaceuticals Ltd) 50 tablet en Synonym Inactive Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Plenadren 20mg modified-release tablets (Takeda UK Ltd) 50 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Plenadren 20mg modified-release tablets (Takeda UK Ltd) 50 tablet Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Plenadren 20mg modified-release tablets (Takeda UK Ltd) 50 tablet Is a Hydrocortisone 20mg modified-release tablets 50 tablet true Inferred relationship Existential restriction modifier
Plenadren 20mg modified-release tablets (Takeda UK Ltd) 50 tablet Has AMP Plenadren 20mg modified-release tablets (Takeda UK Ltd) true Inferred relationship Existential restriction modifier
Plenadren 20mg modified-release tablets (Takeda UK Ltd) 50 tablet Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Plenadren 20mg modified-release tablets (Takeda UK Ltd) 50 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Plenadren 20mg modified-release tablets (Takeda UK Ltd) 50 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Plenadren 20mg modified-release tablets (Takeda UK Ltd) 50 tablet Has specific active ingredient Hydrocortisone true Inferred relationship Existential restriction modifier
Plenadren 20mg modified-release tablets (Takeda UK Ltd) 50 tablet Has dispensed dose form Modified-release oral tablet true Inferred relationship Existential restriction modifier
Plenadren 20mg modified-release tablets (Takeda UK Ltd) 50 tablet Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Plenadren 20mg modified-release tablets (Takeda UK Ltd) 50 tablet Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Plenadren 20mg modified-release tablets (Takeda UK Ltd) 50 tablet Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start